-
Signature
-
By: Stephen T. Wilson (Attorney-In-Fact)
-
Issuer symbol
-
MTB
-
Transactions as of
-
11 Dec 2025
-
Transactions value $
-
-$427,941
-
Form type
-
4
-
Filing time
-
15 Dec 2025, 17:46:24 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| JONES RENE F |
Chairman of the Board and CEO, Director |
ONE M&T PLAZA, BUFFALO |
By: Stephen T. Wilson (Attorney-In-Fact) |
15 Dec 2025 |
0001245773 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
MTB |
Common Stock |
Options Exercise |
$2.62M |
+16.8K |
+18.18% |
$156.00 |
109K |
11 Dec 2025 |
Direct |
F1 |
| transaction |
MTB |
Common Stock |
Tax liability |
-$3.05M |
-14.8K |
-13.56% |
$205.95 |
94.3K |
11 Dec 2025 |
Direct |
F1, F2 |
| holding |
MTB |
Common Stock |
|
|
|
|
|
1.07K |
11 Dec 2025 |
By Daughter #1 |
F3 |
| holding |
MTB |
Common Stock |
|
|
|
|
|
1.07K |
11 Dec 2025 |
By Daughter #2 |
F3 |
| holding |
MTB |
Common Stock |
|
|
|
|
|
6.03K |
11 Dec 2025 |
By 401(k) Plan |
F4 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
MTB |
Option (right to buy) |
Options Exercise |
$0 |
-16.8K |
-66.66% |
$0.00 |
8.39K |
11 Dec 2025 |
Common Stock |
16.8K |
$156.00 |
Direct |
F5, F6 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: